Clinical studies recruiting near Kunming

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Fuwai Yunnan Cardiovascular Hospital · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
Phase 1/Phase 2 · 920th HJointLogistics · 920th Hospital of Joint Logistics Support Force of People's · NCT06675422 Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorec
Phase 2 · Yunnan Cancer Hospital · Fudan University · NCT06521866 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Yunnan Province Cancer Hospital · Pfizer · NCT06758401 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The First People's Hospital of Yunnan Province · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · The First Affiliated Hospital of Kunming Medical University · Jinling Hospital, China · NCT06118840 China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Phase N/A · The First People's Hospital of Yunnan · Second Xiangya Hospital of Central South University · NCT05498974 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · The First Affiliated Hospital of Kunming Medical College · Takeda · NCT07108283 Clinical Trial of TQB3002 in Patients With Advanced Cancers
Phase 1 · Yunnan Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06662760 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Yunnan Cancer Hospital · Shanghai Henlius Biotech · NCT07160335 A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGF
NA · First Affiliated Hospital of Kunming University · Kunming Medical University · NCT06102928 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · First Affiliated Hospital of Kunming Medical University · Eli Lilly and Company · NCT07415044 Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
NA · Research Site · AstraZeneca · NCT07516184 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectiou
Phase N/A · The First People's Hospital of Yunnan Province · Huashan Hospital · NCT05965128 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · The First People's Hospital of Yunnan Province · Eli Lilly and Company · NCT07369011 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · First Affiliated Hospital of Kunming Medical University · Pfizer · NCT05895786 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Yunnan Province Cancer Hospital · Pfizer · NCT07144280 A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Phase 3 · Yunnan Province Hospital of Traditional Chinese Medicine · Tasly Pharmaceutical Group Co., Ltd · NCT06000956 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl
Phase 2 · Yunnan Cancer Hospital · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · Yunnan Tumor Hospital · RemeGen Co., Ltd. · NCT07105215 Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
Phase N/A · The First People's Hospital of Yunnan Province · Huashan Hospital · NCT07694648 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0202 · Celgene · NCT05519085 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · The First People's Hospital of Yunnan Province · Gilead Sciences · NCT06051617 BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
Phase 1/Phase 2 · 920th Hospital of Joint Logistics Support Force · Chongqing Precision Biotech Co., Ltd · NCT04271644 Chinese Psoriasis Real World Evidence Research
Phase N/A · Second Affiliated Hospital, Zhejiang University, School of M · NCT04465838 JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
NA · 920th HJointLogistics · 920th Hospital of Joint Logistics Support Force of People's · NCT07065279 Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)
NA · The First People's Hospital of Yunnan Province · Hangzhou Endonom Medtech Co., Ltd. · NCT06385379 A Study of SKB518 in Patients With Lung Cancer
Phase 2 · Yunnan Cancer Hospital · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · NCT07019675 a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Di
Phase 1/Phase 2 · 920th Hospital of Joint Logistics Support Force · Chongqing Precision Biotech Co., Ltd · NCT04776330

Look up another city

Look up another condition